Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M).

Contemporary clinical trials communications·2025
Same author

The unexplored role of sedentary time and physical activity in glucose and lipid metabolism-related placental mRNAs in pregnant women who are obese: the DALI lifestyle randomised controlled trial.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Patterns of use of oral health care services in Australian rural adults: the Crossroads-II Dental sub-study.

Australian dental journal·2021
Same author

Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

RUNX1T1 rs34269950 is associated with obesity and metabolic syndrome.

QJM : monthly journal of the Association of Physicians·2020
Same journal

Refining metabolic-response signals after liraglutide therapy in type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Finger-stick glucose testing as an institutional stressor: Staff perspectives from long-term care.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Prevalence, duration, and clinical implications of continuous glucose monitor measurement limit capping in type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Disentangling the effect of brain insulin resistance on brain health (BIR-BrainHealth): Rationale and study protocol.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Clinical characteristics and in-hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open-loop era: A UK-wide MINAP registry analysis.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?

Diabetic medicine : a journal of the British Diabetic Association·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Does a diabetes annual review make a difference?

T Kenealy1, B Orr-Walker, R Cutfield

  • 1University of Auckland, South Auckland Clinical School, Middlemore Hospital, Otahuhu, Auckland, New Zealand. t.kenealy@auckland.ac.nz

Diabetic Medicine : a Journal of the British Diabetic Association
|December 7, 2011
PubMed
Summary
This summary is machine-generated.

This study examined whether formal yearly diabetes check-ups lead to better patient health outcomes compared to routine care. Researchers analyzed thousands of medical audits and found that while patient health markers improved over time, these gains were mostly unrelated to the specific annual review process. The authors suggest that current payment models for these reviews should shift toward rewarding actual improvements in patient health rather than just the completion of paperwork.

Keywords:
metabolic controlclinical inertiahealth policylongitudinal audit

Frequently Asked Questions

Related Experiment Videos

Last Updated: May 26, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Area of Science:

  • Diabetes annual review outcomes research within primary care medicine
  • Clinical epidemiology and health services research

Background:

Chronic disease management requires consistent monitoring to prevent long-term complications. No prior work had resolved whether specific yearly check-ups provide unique benefits beyond standard care. That uncertainty drove this investigation into clinical performance metrics. It was already known that metabolic markers often fluctuate over time in patients with long-term conditions. This gap motivated a rigorous look at whether structured reviews drive these observed changes. Prior research has shown that general practice workflows are complex and multifaceted. Researchers often struggle to isolate the impact of a single administrative event. This study addresses how these specific check-ups influence patient health data.

Purpose Of The Study:

The study aimed to determine if yearly check-ups improve patient health markers independently of other care processes. Researchers sought to clarify the specific value added by these administrative events in general practice. This investigation addressed whether current clinical workflows are sufficient for managing chronic metabolic conditions. The team explored if the review process itself drives positive changes in patient data. They examined the relationship between check-up timing and shifts in clinical performance. The motivation stemmed from the need to evaluate the efficacy of existing healthcare funding models. By isolating the review effect, the authors hoped to inform future policy decisions. This work provides a critical assessment of whether current practices meet meaningful clinical goals.

Main Methods:

The investigation employed a longitudinal design to track patient health markers over several years. Reviewers examined audit records gathered from numerous medical practices between 2003 and 2008. Analysts utilized a time-trend approach to evaluate shifts in clinical performance. Each participant functioned as their own control to minimize external variability. The team applied an interaction variable to compare gradients before and after the intervention. This methodology isolated the specific contribution of the check-up from routine care. Researchers processed thousands of individual records to ensure statistical robustness. The approach focused on identifying whether administrative events altered long-term health trajectories.

Main Results:

The strongest finding indicates that metabolic control improved over time independently of the specific check-up. Predicted HbA1c levels decreased by 0.13% following the intervention. HDL cholesterol levels showed a minor increase of 0.04 mmol/L. Triglyceride levels exhibited a reduction of 0.2 mmol/L. Systolic blood pressure measurements did not demonstrate a statistically significant change. Diastolic blood pressure also remained stable throughout the observation period. Urinary albumin to creatinine ratios showed no meaningful shift after the review. These results suggest that standard practice processes account for most observed health improvements.

Conclusions:

The authors suggest that yearly check-ups provide minimal added clinical benefit. Existing primary care workflows appear to drive most observed improvements in metabolic markers. Payment models currently prioritize the completion of administrative tasks over patient outcomes. The researchers propose shifting financial incentives toward achieving meaningful health targets. Systematic feedback mechanisms could help address clinical inertia in general practice. Future policies should focus on management changes rather than simple data collection. The evidence indicates that the current review process lacks significant independent value. These findings imply that current funding structures require substantial revision to improve care quality.

The researchers propose that the review process provides little independent value. While metabolic markers like HbA1c decreased by 0.13% and HDL cholesterol rose by 0.04 mmol/L, these changes were largely independent of the specific annual check-up event.

The study utilized an interaction variable between the review event and the year of audit. This statistical approach allowed each patient to serve as their own control, comparing health trends before and after the intervention.

The authors argue that the current payment structure is insufficient because it rewards data collection rather than health outcomes. They propose that funding should instead target clinical management changes to combat inertia.

The dataset comprised 9471 individual audits collected from 3397 patients across 92 different practices. This large-scale information provided the basis for evaluating longitudinal trends in metabolic control.

The study measured several markers, including HbA1c, systolic blood pressure, and lipids. While HbA1c and triglycerides showed minor decreases, systolic blood pressure and urinary albumin:creatinine ratios remained unchanged after the review.

The authors suggest that annual review results should be integrated into systematic feedback loops. They claim this approach would better support practitioners in overcoming clinical inertia during patient management.